List of Tables
Table 1. Global Rifaximin Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rifaximin Tablets Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Rifaximin Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rifaximin Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rifaximin Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rifaximin Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rifaximin Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rifaximin Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rifaximin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rifaximin Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rifaximin Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Rifaximin Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rifaximin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rifaximin Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rifaximin Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Rifaximin Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Rifaximin Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Rifaximin Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Rifaximin Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rifaximin Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Rifaximin Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rifaximin Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Rifaximin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rifaximin Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Rifaximin Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Rifaximin Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rifaximin Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rifaximin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rifaximin Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rifaximin Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rifaximin Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rifaximin Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rifaximin Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rifaximin Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rifaximin Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rifaximin Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rifaximin Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rifaximin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rifaximin Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rifaximin Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rifaximin Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rifaximin Tablets Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Rifaximin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Rifaximin Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Rifaximin Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Rifaximin Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Rifaximin Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rifaximin Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Rifaximin Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Rifaximin Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Rifaximin Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Rifaximin Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rifaximin Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rifaximin Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Rifaximin Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Rifaximin Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Rifaximin Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Rifaximin Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Rifaximin Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Rifaximin Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Rifaximin Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Rifaximin Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rifaximin Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rifaximin Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Rifaximin Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Rifaximin Tablets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Rifaximin Tablets Price (US$/Unit) by Application (2025-2030)
Table 70. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information
Table 71. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 74. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
Table 76. Chongqing Laimi Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 79. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
Table 81. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 84. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
Table 86. Chongqing Sino Biopharmaceutical Co., Ltd. Description and Business Overview
Table 87. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 89. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Nanchang Feihong Pharmaceutical Co., Ltd. Company Information
Table 91. Nanchang Feihong Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 94. Nanchang Feihong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Sichuan Baili Pharmaceutical Co., Ltd. Company Information
Table 96. Sichuan Baili Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 99. Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Tianjin Junan Biopharmaceutical Co., Ltd. Company Information
Table 101. Tianjin Junan Biopharmaceutical Co., Ltd. Description and Business Overview
Table 102. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 104. Tianjin Junan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
Table 106. Shenyang Tonglian Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 109. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information
Table 111. Sichuan Mingxing Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product
Table 114. Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Gnova Biotech Company Information
Table 116. Gnova Biotech Description and Business Overview
Table 117. Gnova Biotech Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Gnova Biotech Rifaximin Tablets Product
Table 119. Gnova Biotech Recent Developments/Updates
Table 120. Alfasigma SpA Company Information
Table 121. Alfasigma SpA Description and Business Overview
Table 122. Alfasigma SpA Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Alfasigma SpA Rifaximin Tablets Product
Table 124. Alfasigma SpA Recent Developments/Updates
Table 125. Estrellas Life Sciences Private Limited Company Information
Table 126. Estrellas Life Sciences Private Limited Description and Business Overview
Table 127. Estrellas Life Sciences Private Limited Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Estrellas Life Sciences Private Limited Rifaximin Tablets Product
Table 129. Estrellas Life Sciences Private Limited Recent Developments/Updates
Table 130. Healthy Life Pharma Pvt. Ltd. Company Information
Table 131. Healthy Life Pharma Pvt. Ltd. Description and Business Overview
Table 132. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product
Table 134. Healthy Life Pharma Pvt. Ltd. Recent Developments/Updates
Table 135. Aden Healthcare Company Information
Table 136. Aden Healthcare Description and Business Overview
Table 137. Aden Healthcare Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Aden Healthcare Rifaximin Tablets Product
Table 139. Aden Healthcare Recent Developments/Updates
Table 140. Norgine Limited Company Information
Table 141. Norgine Limited Description and Business Overview
Table 142. Norgine Limited Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Norgine Limited Rifaximin Tablets Product
Table 144. Norgine Limited Recent Developments/Updates
Table 145. Netprime Pharma Company Information
Table 146. Netprime Pharma Description and Business Overview
Table 147. Netprime Pharma Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Netprime Pharma Rifaximin Tablets Product
Table 149. Netprime Pharma Recent Developments/Updates
Table 150. AS Lifesciences Company Information
Table 151. AS Lifesciences Description and Business Overview
Table 152. AS Lifesciences Rifaximin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. AS Lifesciences Rifaximin Tablets Product
Table 154. AS Lifesciences Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Rifaximin Tablets Distributors List
Table 158. Rifaximin Tablets Customers List
Table 159. Rifaximin Tablets Market Trends
Table 160. Rifaximin Tablets Market Drivers
Table 161. Rifaximin Tablets Market Challenges
Table 162. Rifaximin Tablets Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Rifaximin Tablets
Figure 2. Global Rifaximin Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rifaximin Tablets Market Share by Type: 2023 & 2030
Figure 4. 0.1g Product Picture
Figure 5. 0.2g Product Picture
Figure 6. Global Rifaximin Tablets Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Rifaximin Tablets Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Rifaximin Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Rifaximin Tablets Market Size (2019-2030) & (US$ Million)
Figure 13. Global Rifaximin Tablets Sales (2019-2030) & (K Units)
Figure 14. Global Rifaximin Tablets Average Price (US$/Unit) & (2019-2030)
Figure 15. Rifaximin Tablets Report Years Considered
Figure 16. Rifaximin Tablets Sales Share by Manufacturers in 2023
Figure 17. Global Rifaximin Tablets Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Rifaximin Tablets Players: Market Share by Revenue in Rifaximin Tablets in 2023
Figure 19. Rifaximin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Rifaximin Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Rifaximin Tablets Sales Market Share by Country (2019-2030)
Figure 22. North America Rifaximin Tablets Revenue Market Share by Country (2019-2030)
Figure 23. United States Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Rifaximin Tablets Sales Market Share by Country (2019-2030)
Figure 26. Europe Rifaximin Tablets Revenue Market Share by Country (2019-2030)
Figure 27. Germany Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Rifaximin Tablets Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Rifaximin Tablets Revenue Market Share by Region (2019-2030)
Figure 34. China Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Rifaximin Tablets Sales Market Share by Country (2019-2030)
Figure 42. Mexico Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Rifaximin Tablets Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Rifaximin Tablets Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Rifaximin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Rifaximin Tablets by Type (2019-2030)
Figure 52. Global Revenue Market Share of Rifaximin Tablets by Type (2019-2030)
Figure 53. Global Rifaximin Tablets Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Rifaximin Tablets by Application (2019-2030)
Figure 55. Global Revenue Market Share of Rifaximin Tablets by Application (2019-2030)
Figure 56. Global Rifaximin Tablets Price (US$/Unit) by Application (2019-2030)
Figure 57. Rifaximin Tablets Value Chain
Figure 58. Rifaximin Tablets Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
